
Old drug, in a low dose, safe and effective in preventing progression of type 1 diabetes in children and young people
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a much lower dose than […]